162
Views
13
CrossRef citations to date
0
Altmetric
Original

The expression of the Peripheral Cannabinoid receptor on cells of the immune system and Non-Hodgkin's lymphomas

, , , , , , & show all
Pages 1389-1399 | Received 05 Dec 2006, Accepted 31 Mar 2007, Published online: 01 Jul 2009

References

  • Matsuda L A, Lolait S J, Brownstein M J, Young A C, Bonner T I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561–564
  • Matsuda L A, Bonner T I, Lolait S J. Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 1993; 327: 535–550
  • Herkenham M. Characterization and localization of cannabinoid receptors in brain: an in vitro technique using slide-mounted tissue sections. NIDA Res Monogr 1991; 112: 129–145
  • Kaminski N E, Abood M E, Kessler F K, Martin B R, Schatz A R. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol Pharmacol 1992; 42: 736–742
  • Twitchell W, Brown S, Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol 1997; 78: 43–50
  • Farquhar-Smith W P, Egertova M, Bradbury E J, McMahon S B, Rice A S, Elphick M R. Cannabinoid CB(1) receptor expression in rat spinal cord. Mol Cell Neurosci 2000; 15: 510–521
  • Munro S, Thomas K L, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365: 61–65
  • Bouaboula M, Rinaldi M, Carayon P, Carillon C, Delpech B, Shire D. Cannabinoid-receptor expression in human leukocytes. Eur J Biochem 1993; 214: 173–180
  • Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995; 232: 54–61
  • Carayon P, Marchand J, Dussossoy D, Derocq J M, Jbilo O, Bord A, et al. Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood 1998; 92: 3605–3615
  • Bouaboula M, Dussossoy D, Casellas P. Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses. J Biol Chem 1999; 274: 20397–20405
  • Rayman N, Lam K H, Laman J D, Simons P J, Lowenberg B, Sonneveld P, et al. Distinct expression profiles of the peripheral cannabinoid receptor in lymphoid tissues depending on receptor activation status. J Immunol 2004; 172: 2111–2117
  • Buckley N E, McCoy K L, Mezey E, Bonner T, Zimmer A, Felder C C, et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 2000; 396: 141–149
  • Flygare J, Gustafsson K, Kimby E, Christensson B, Sander B. Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma. FEBS Lett 2005; 579: 6885–6889
  • McKallip R J, Lombard C, Fisher M, Martin B R, Ryu S, Grant S, et al. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 2002; 100: 627–634
  • Jorda M A, Rayman N, Valk P, De Wee E, Delwel R. Identification, characterization, and function of a novel oncogene: the peripheral cannabinoid receptor Cb2. Ann NY Acad Sci 2003; 996: 10–16
  • Doorduijn J K, van der Holt B, van Imhoff G W, van der Hem K G, Kramer M H, van Oers M H, et al. CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. J Clin Oncol 2003; 21: 3041–3050
  • Schatz A R, Lee M, Condie R B, Pulaski J T, Kaminski N E. Cannabinoid receptors CB1 and CB2: a characterizatiion of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 1997; 142: 278–287
  • Rao G K, Kaminski N E. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship. J Pharmacology Exp Ther 2006; 317: 820–829
  • Wiley J L, Martin B R. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes. Chem Phys Lipid 2002; 121: 57–63
  • Mo F M, Offertaler L, Kunos G. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1. Exp J Pharmacol 2004; 489: 21–27
  • Breivogel C S, Griffin G, Di Marzo V, Martin B R. Evidence for a new G protein-coupled cannabinoid receptor. Mol Pharmacol 2001; 60: 155–163

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.